Multiplex Assay Kit for Cluster Of Differentiation 26 (CD26) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD26; ADA; DPPIV; DPP-IV; DPP4; ADABP; ADCP2; TP103; Adenosine Deaminase Complexing Protein 2; T-cell activation antigen CD26; Dipeptidyl Peptidase IV

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Cluster Of Differentiation 26 (CD26) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Cluster Of Differentiation 26 (CD26) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Cluster Of Differentiation 26 (CD26) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Cluster Of Differentiation 26 (CD26) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 85-101 91
EDTA plasma(n=5) 94-105 101
heparin plasma(n=5) 84-91 88
sodium citrate plasma(n=5) 95-102 98

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cluster Of Differentiation 26 (CD26) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cluster Of Differentiation 26 (CD26) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Cluster Of Differentiation 26 (CD26) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 87-97% 85-92% 80-95% 87-94%
EDTA plasma(n=5) 80-101% 78-90% 80-103% 87-98%
heparin plasma(n=5) 86-101% 88-96% 87-94% 83-90%
sodium citrate plasma(n=5) 97-105% 78-93% 88-95% 90-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CD26) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
hormone and metabolic research Linagliptin Blocks Renal Damage in Type 1 Diabetic Rats by Suppressing Advanced Glycation End Products-Receptor Axis Pubmed: 24710699
Curr Med Chem. MK-0626, a dipeptidyl peptidase-4 inhibitor, improves neovascularization by increasing both the number of circulating endothelial progenitor cells and endothelial nitric oxide synthetase expression. Pubmed:24059225
Diabetes Ghrelin inhibition restores glucose homeostasis in hepatocyte nuclear factor-1alpha (MODY3) deficient mice PubMed: 25979074
The American Journal of the Medical Sciences Expression and Clinical Significance of Serum Dipeptidyl Peptidase IV Chronic Obstructive Pulmonary Disease Pubmed:26992252
Gene Expression of recombinant human α-lactalbumin in milk of transgenic cloned pigs is sufficient to enhance intestinal growth and weight gain of suckling piglets Pubmed:26899869
Applied In Vitro Toxicology Hepatic Spheroids for Long-Term Toxicity Studies aivt.2016.0016
BMJ Open Diab Res Care High circulating plasma dipeptidyl peptidase- 4 levels in non-obese Asian Indians with type 2 diabetes correlate with fasting insulin and LDL-C levels, triceps skinfolds, total intra-abdominal adipose tissue volume and presence of diabetes: a case–control study 10.1136:bmjdrc-2017-000393
Diabetology & Metabolic Syndrome Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2 pubmed:28450900
Journal of Cellular Biochemistry The effect of CD26‐deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease Pubmed:29693275
Medicine (Baltimore) Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity Pubmed:29953010
Sci Rep The novel adamantane derivatives as potential mediators of inflammation and neural plasticity in diabetes mice with cognitive impairment Pubmed:35468904
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA884Hu01 Recombinant Cluster Of Differentiation 26 (CD26) Positive Control; Immunogen; SDS-PAGE; WB.
APA884Hu01 Active Cluster Of Differentiation 26 (CD26) Cell culture; Activity Assays.
PAA884Hu01 Polyclonal Antibody to Cluster Of Differentiation 26 (CD26) WB; IHC; ICC; IP.
LAA884Hu71 Biotin-Linked Polyclonal Antibody to Cluster Of Differentiation 26 (CD26) WB; IHC; ICC.
RAA884Hu22 Recombinant Antibody to Cluster Of Differentiation 26 (CD26) WB; IF; ICC; IHC; IP; FCM.
MAA884Hu21 Monoclonal Antibody to Cluster Of Differentiation 26 (CD26) WB; IHC; ICC; IP.
MAA884Hu23 Monoclonal Antibody to Cluster Of Differentiation 26 (CD26) WB; IHC; ICC; IP.
MAA884Hu24 Monoclonal Antibody to Cluster Of Differentiation 26 (CD26) WB; IHC; ICC; IP.
MAA884Hu22 Monoclonal Antibody to Cluster Of Differentiation 26 (CD26) WB; IHC; ICC; IP.
SEA884Hu ELISA Kit for Cluster Of Differentiation 26 (CD26) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA884Hu Multiplex Assay Kit for Cluster Of Differentiation 26 (CD26) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.